Plasma levels of bupivacaine were measured following lumbar epidural administration of 3 mg/kg of 0.5% plain solution in sixteen children. The peak levels were generally between 1.0 and 2I1g/ml, the highest being 2.9 I1g/ml. No manifestations of toxicity were observed. There was a significant positive correlation between peak plasma levels and increasing age.
Epidural bupivacaine provides good operating conditions and postoperative analgesia. In paediatric anaesthesia the caudal route is the more commonly used site for access to the epidural space. The lumbar route is useful particularly for abdominal surgery. However, the anaesthetist has to be familiar with the technique and be aware of the anatomical differences between children and adults.
The toxic plasma concentration of bupivacaine has not been fully defined. Our previous studies in children 1.2 showed that doses of 2 and 3 mg/kg of 0.25070 bupivacaine hydrochloride (Marcaine) given by the caudal route produced plasma concentrations which did not cause any toxic or adverse reactions.
The present study extends the evaluation of bupivacaine doses for children by measuring the plasma concentrations following lumbar epidural administration of 3 mg/kg of 0.5070 plain solution. The effect of age on the peak plasma concentration and the time-to-peak were investigated. METHODS Sixteen children aged from two to eleven years admitted for routine elective surgery were admitted. This study is one of the series relating to the local anaesthetic plasma levels that have been approved by the Ethics Committee at the Royal Children's Hospital, Melbourne.
The patients were premedicated with papaveretum 0.4 mg/kg and hyoscine 0.08 mg/kg. General anaesthesia was induced with thiopentone and light general anaesthesia was maintained with nitrous oxide and oxygen. Muscle relaxants, alcuronium or d-tubocurarine, were administered for all surgical procedures where intubation was required. Otherwise, for those patients breathing spontaneously, a thiopentone induction followed by nitrous oxide, oxygen and 0.5070 halothane was used for maintenance. With this technique, PaC02 remained within the range 35-42 mmHg as measured by spot bloodgas analysis. Following induction the child was turned on the side and, under aseptic conditions, the epidural space at L2-3 was identified by loss of resistance using a shortbevelled 22-gauge Portland lumbar puncture needle. Bupivacaine HCl 0.5070 plain 3 mg/kg was then injected. At the completion of the injection, the patient was immediately turned supine.
For the analysis of results, no distinction was made between male and female patients nor between those breathing spontaneously or being ventilated.
Venous biood samples of at least 0.6 ml were collected in heparinised syringes following withdrawal of an initial aliquot greater than the dead-space of the venous line. Blood samples were taken from either the induction cannula or an intravenous line in t!1e arm via a three-way tap. Following an initial control sample taken before injection, the time sequence for sampling was 2.5,5,7.5, 10, 12, 14, 16, IS, 20, 25, 30, 45 and 60 minutes. This sequence was used to provide the most frequent sampling intervals during the time of the expected peak plasma levels. In some cases a 60-minute sample could not be obtained as sampling was restricted to the surgical period. Samples were taken over 10 seconds, beginning 5 seconds prior to and finishing 5 seconds after the specified time.
After collection, the blood was centrifuged and the plasma removed with a Pasteur pipette. The plasma was stored in glass vials at -20 QC until required for extraction and analysis.
The extraction procedure consisted of dilution of the sample with distilled water, the addition of 1 I1g of lignocaine hydrochloride as an internal standard and ether extraction following alkalinisation with sodium hydroxide. The extract was then acidified with 100 111 of 0.005 molar sulphuric acid, the ether layer separated and discarded, the remaining fraction neutralised with 0.1 molar sodium hydroxide and used for analysis. This method enabled as little as 100 111 of plasma to be successfully analysed.
Analysis of bupivacaine HCl in plasma was conducted using high performance liquid chromatography with UV detection at 2.05 mm (Perkin Elmer L-75 variable wavelength detector). Chromatography was performed by a CS column (Dupont, Zorbax CS) and a mobile phase was buffered by 0.2% orthophosphoric acid, the pH being adjusted to 7.00 with strong ammonia solution. The mobile phase elution rate was 1.5 mllmin and total chromatography time was 15 minutes.
All plasma levels were expressed as I1g/ml of bupivacaine HCl. The coefficient of variation for extraction was less than 5% while the coefficient of variation for measurement was 2.S6% at 1.0 I1g/ml and at 2.12% at 2 I1g/ml.
For comparison of mean concentration for different age groups and time to peak, the statistical program ML TCOMP was used. MLTCOMP conducts a multiple t-test. Significance was set at less than 0.05. Figure 1 there was a significant positive correlation between the peak plasma concentration and increasing patient age (r =0.572, P<0.05). There was also a positive correlation between the peak plasma concentration and the dose administered (r = 0.623, P<0.05). The correlation coefficient for peak plasma level versus dose administered (r = 0.623) is greater than for patient age (r = 0.572). Both are significant (P<0.05).
RESULTS

As shown in
Using linear regression analysis between peak plasma levels of bupivacaine HCl and time, no significant correlation (r = 0.3S7, P<0.05) between the time to peak and the patient age was found.
In Figure 2 our previous study on caudal administration 2 (3 mg/kg of 0.25% bupivacaine) is compared with this study. The :::; patients in both studies were divided into the age groups shown. The mean plasma levels for all the age groups with caudal anaesthesia 2 fell in the shaded area. Representative error bars (SEM) are included in the figure for patients over 5 years who received lumbar epidural bupivacaine. The standard error of the mean was similar for both studies. Figure 2 shows that plasma levels are higher in the older children following lumbar epidural administration. There is a statistically significant difference between children under three years and over five years at 18 minutes and from 25 to 60 minutes following injection. At 60 minutes, the mean concentration for patients under three years is significantly lower than that of patients greater than three years.
No sign of toxicity was noted in any of the patients during the study.
DISCUSSION
The peak plasma concentrations ranged from 0.94 to 2.93 /Ag/ml of bupivacaine HCI following lumbar epidural administration compared with 0.78-2.00 /Ag/ml following the same dose given by the caudal route in a 0.25070 solution. 2 Comparison with previously reported adult studies is difficult because of the diversity of The mean plasma levels for caudal administration for the same dose in all age groups fell in the shaded area. ( doses, volumes and concentrations used. 3 -9 Peak bupivacaine concentrations in adult studies have ranged from 0.5 /Ag/mI 8 to 1.5 /Ag/mF when used in 20 ml of 0.5% solution and 225 mg of 0.75% solution respectively. The time taken to reach the peak venous concentration ranged from 12 to 30 minutes. Generally, a plateau concentration existed between 10 and 30 minutes after injection with some fluctuation about an assumed steady level. Following this, the plasma levels gradually declined. In adult studies, peak concentrations have been reported between 10 and 30 minutes, after which levels decrease. 3 -5 ,1O In this study, blood levels were higher throughout in the older children. There was no significant difference in the mean plasma concentrations between the age groups following caudal administration in our previous study. 2 That peak plasma bupivacaine concentration in this study was greater with increased age implies that there is a difference in absorption or distribution between young and older children following lumbar epidural injection.
As there are a number of factors which influence the toxicity of amide local anaesthetics apart from plasma concentration such as the rate of rise of concentration within the plasma or the plasma pH, it is hard to state a specific safe plasma level. Albright" drew attention to the toxicity problem of the newer, more potent anaesthetic agents, bupivacaine and etidocaine. Unlike the older agents lignocaine and procaine, the newer drugs do not exhibit the range of safety between central nervous system convulsions and cardiac toxicity, and in fact there may be almost simultaneous seizures and cardiovascular collapse from the clinical doses inadvertently administered intravenously .
More recently a review by Kendig I2 and work by Clarkson 13 has thrown an interesting light on binding and the kinetics of interaction with the cardiac sodium channels.
